PD-L1 expression is regulated by ATP-binding of the ERBB3 pseudokinase domain
How PD-L1 expression is regulated in cancer is poorly understood. Here, we report that the ATP-binding activity of ERBB3 pseudokinase regulates PD-L1 gene expression in colorectal cancers (CRCs). ERBB3 is one of the four members of the EGF receptor family, all with protein tyrosine kinase domains. E...
Main Authors: | Yamu Li, Zhonghua Liu, Yiqing Zhao, Jie Yang, Tsan Sam Xiao, Ronald A. Conlon, Zhenghe Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2023-07-01
|
Series: | Genes and Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S235230422200304X |
Similar Items
-
Hyperactivation of Oncogenic JAK3 Mutants Depend on ATP Binding to the Pseudokinase Domain
by: Juuli Raivola, et al.
Published: (2018-12-01) -
Structure of Fam20A reveals a pseudokinase featuring a unique disulfide pattern and inverted ATP-binding
by: Jixin Cui, et al.
Published: (2017-04-01) -
PK1 from Drosophila obscurin is an inactive pseudokinase with scaffolding properties
by: Thomas Zacharchenko, et al.
Published: (2023-04-01) -
Titin kinase is an inactive pseudokinase scaffold that supports MuRF1 recruitment to the sarcomeric M-line
by: Julijus Bogomolovas, et al.
Published: (2014-01-01) -
Afatinib combined with anti-PD1 enhances immunotherapy of hepatocellular carcinoma via ERBB2/STAT3/PD-L1 signaling
by: Chao Yu, et al.
Published: (2023-05-01)